Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac for pain and inflammation after pterygium surgery
NCT04022811Phase 4Completed
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Oct 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bromfenac sodium in ocular inflammation, sponsored by Zhongshan Ophthalmic Center. Started Oct 2016; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT04022811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022811.